Artemisinic Acid Market Share, Size, Industry Trends, Opportunity and Forecast 2024-2032

IMARC Group, a leading market research company, has recently releases report titled “Artemisinic Acid Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,” The study provides a detailed analysis of the industry, including the global artemisinic acid market size, share, trends, and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the artemisinic acid market?

The global artemisinic acid market size reached US$ 729.78 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,043.42 Million by 2032, exhibiting a growth rate (CAGR) of 4.05% during 2024-2032.

Factors Affecting the Growth of the Artemisinic Acid Industry:

• Rising Prevalence of Malaria and Drug-Resistant Strains:

One of the primary drivers of growth in the artemisinic acid market is the persistent threat of malaria, particularly in regions with high transmission rates such as sub-Saharan Africa, Southeast Asia, and parts of South America. Despite ongoing efforts to control and eliminate malaria, the disease remains a significant global health burden, causing hundreds of thousands of deaths each year, primarily among children under five years old. Artemisinin-based combination therapies (ACTs), derived from artemisinic acid, are the most effective treatments for malaria recommended by the World Health Organization (WHO). However, the emergence of drug-resistant strains of the malaria parasite, particularly in Southeast Asia, underscores the urgent need for new and improved antimalarial drugs. As a result, there is a growing demand for artemisinic acid as a key precursor in the synthesis of artemisinin and other artemisinin derivatives used in ACTs, driving market growth and innovation in artemisinin production technologies.

• Increasing Investment in Research and Development:

Another significant factor influencing the growth of the artemisinic acid market is the increasing investment in research and development (R&D) to advance artemisinin production technologies and develop new artemisinin-based antimalarial drugs. With the support of governments, non-profit organizations, and pharmaceutical companies, there has been significant progress in improving the efficiency, scalability, and cost-effectiveness of artemisinin production through biotechnological approaches such as synthetic biology, metabolic engineering, and fermentation. These advancements enable the sustainable and environmentally friendly production of artemisinic acid from genetically engineered microorganisms or plants, reducing reliance on traditional extraction methods from Artemisia annua plants. Moreover, ongoing R&D efforts aim to overcome the challenges of artemisinin resistance and ensure the availability of effective antimalarial drugs for future generations, driving innovation and growth in the artemisinic acid market.

• Expanding Applications Beyond Antimalarial Drugs:

In addition to its role in antimalarial drug production, artemisinic acid is finding new applications in the pharmaceutical and healthcare industries, further driving market growth. Recent studies have demonstrated the potential therapeutic benefits of artemisinic acid and its derivatives in treating other diseases such as cancer, autoimmune disorders, and infectious diseases beyond malaria. Artemisinic acid exhibits promising anti-inflammatory, immunomodulatory, and anticancer properties, making it a valuable candidate for drug discovery and development in various therapeutic areas. Furthermore, artemisinic acid-derived compounds show potential as novel drug candidates for combating multidrug-resistant bacteria and viruses, addressing the growing threat of antimicrobial resistance. As research into the pharmacological properties of artemisinic acid continues to expand, the market for artemisinic acid is expected to grow, driven by the development of new pharmaceutical products and therapeutic applications beyond antimalarial drugs.

Request a PDF Sample of the Report: https://www.imarcgroup.com/artemisinic-acid-market/requestsample

Artemisinic Acid Market Report Segmentation:

Breakup By Type:

• Antimalarial Injections
• Antimalarial Tablets

Antimalarial tablets represent the largest market segment by type within the global artemisinic acid market, primarily due to the high prevalence of malaria in many regions, which drives the demand for effective treatment options.

Breakup By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

The Middle East and Africa region lead to the market due to the significant malaria burden in these areas, necessitating a strong demand for antimalarial drugs, including those derived from artemisinin.

Global Artemisinic Acid Market Trends:

The global artemisinic acid market is experiencing notable trends driven by the increasing demand for artemisinin-based antimalarial drugs and the growing interest in natural and plant-based pharmaceutical ingredients. Artemisinic acid, derived from the Artemisia annua plant, serves as a key precursor in the synthesis of artemisinin, the most effective treatment for malaria. One prominent trend is the expanding use of artemisinic acid in the pharmaceutical industry to produce artemisinin-based combination therapies (ACTs) to combat drug-resistant strains of malaria.

Additionally, there is a rising focus on sustainable and environmentally friendly production methods for artemisinic acid, including biotechnological approaches such as synthetic biology and metabolic engineering, to meet the growing demand for artemisinin derivatives while reducing reliance on traditional extraction methods.

Some of these key players include:

• AdvaCare Pharma
• Guilin pharmaceutical Co.Ltd. (Shanghai Fosun Pharmaceutical Co., Ltd)
• KPC Pharmaceuticals Inc.
• Novartis AG
• Rupus Global Limited
• Shin Poong Pharm Co. Ltd.

Browse the full report with TOC and List of Figures: https://www.imarcgroup.com/artemisinic-acid-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163

Article source: https://article-realm.com/article/Business/58416-Artemisinic-Acid-Market-Share-Size-Industry-Trends-Opportunity-and-Forecast-2024-2032.html